Exagen (XGN) EBT (2018 - 2026)

Exagen (XGN) has reported EBT for 9 consecutive years, with -$3.9 million the latest figure, recorded in Q1 2026.

• EBT for Q1 2026 came in at -$3.9 million, down 4.77% year-over-year; the trailing twelve-month figure through Mar 2026 was -$20.1 million (down 29.58% YoY), and the FY2025 annual result was -$19.9 million, down 31.76% from the prior year.
• EBT was -$3.9 million for Q1 2026 at Exagen, up from -$4.7 million in the prior quarter.
• Over five years, EBT peaked at -$3.0 million in Q2 2024 and troughed at -$15.1 million in Q4 2022.
• Average EBT over 5 years is -$6.5 million, with a median of -$5.0 million recorded in 2024.
• Year-over-year, EBT tumbled 128.86% in 2022 and jumped 65.83% in 2023.
• Over 5 years, EBT stood at -$15.1 million in 2022, then surged by 63.35% to -$5.5 million in 2023, then jumped by 32.33% to -$3.7 million in 2024, then slipped by 24.3% to -$4.7 million in 2025, then grew by 15.64% to -$3.9 million in 2026.
• Per Business Quant data, the three most recent EBT figures were -$3.9 million in Q1 2026, -$4.7 million in Q4 2025, and -$7.1 million in Q3 2025.